Last updated 2026-08-21
- Raised $75M Series E led by Novo Holdings, Jan 2024
- Raised $14.4M E Round Extension led by LYFE Capital, Oct 2025
- Raised $17.4M Series D led by LYFE Capital, Feb 2021
Total raised
$121.4M
Stage
—
Founded
2013
Headcount
—
HQ
Cleveland, OH, United States
Sector
Healthcare
About
Cleveland Diagnostics is a precision oncology company focused on changing the shape of cancer detection. The company has unlocked the diagnostic power of protein structure with its revolutionary IsoClear™ platform that enables novel diagnostics based on a cancer-specific, protein structure-based assessment using easy to execute tests within the clinical lab setting. Their first product, IsoPSA, is a blood-based prostate cancer test indicated as an aid in the decision for prostate biopsy for men ≥ 50 years of age with elevated PSA levels.
Funding history · 6 rounds · $121.4M total
6 events/rounds · $121.4M Total Funding: $121.4M in Private Equity
Oct 2025
★ LYFE Capital6 moreNovo HoldingsJobsOhio VenturesCleveland Clinic VenturesSerial Stage Venture PartnersNottingham Unlimited Ventures
Jan 2024
★ Novo HoldingsSymbiotic Capital
Feb 2021
Dec 2016
Jan 2016
Mar 2015
★ Novo Holdings★ JobsOhio Ventures★ Cleveland Clinic Ventures★ Serial Stage Venture Partners★ Nottingham Unlimited Ventures
Offices
Cleveland, OH, United States · HQ / main office
Q&A
- What is Cleveland Diagnostics' primary focus?
- Cleveland Diagnostics is a precision oncology company focused on changing the shape of cancer detection.
- What is Cleveland Diagnostics' flagship product?
- Cleveland Diagnostics' first product is IsoPSA, a blood-based prostate cancer test indicated as an aid in the decision for prostate biopsy for men ≥ 50 years of age with elevated PSA levels.
- What technology does Cleveland Diagnostics utilize for its diagnostics?
- Cleveland Diagnostics utilizes its revolutionary IsoClear™ platform, which enables novel diagnostics based on a cancer-specific, protein structure-based assessment using easy to execute tests within the clinical lab setting.
- When was Cleveland Diagnostics founded?
- Cleveland Diagnostics was founded in 2013.
- Who are the founders of Cleveland Diagnostics?
- The founders of Cleveland Diagnostics are Arnon Chait, Chief Innovation Officer, and Boris Zaslavsky, Chief Scientific Officer.
- Who is the current CEO of Cleveland Diagnostics?
- Michael Iskra was appointed Chief Executive Officer of Cleveland Diagnostics in January 2026.
- What is Cleveland Clinic's relationship with Cleveland Diagnostics?
- Cleveland Clinic co-founded Cleveland Diagnostics and is a shareholder, holding a minority stake.
- Which sectors does Cleveland Diagnostics operate in?
- Cleveland Diagnostics operates in the Healthcare, Biotechnology, and Medical Diagnostics sectors, with a focus on Oncology and Prostate Cancer.
Sectors & technology
Primary sector
Healthcare
Technologies
Target customers
Business model
B2BB2C
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | clevelanddx.com |
|---|
Identifiers & details
| Legal name | Cleveland Diagnostics, Inc. |
|---|---|
| Founded | 2013 |
Radar intelligence
Web history (Wayback)
| Domain | clevelanddx.com |
|---|